YUBO INTERNATIONAL BIOTECH LIMITED — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a9e05147-b9b3-4dce-b8f9-4fb54e20c097/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.1M | 2025-01-01 – 2025-12-31 | evidence 0001640334-26-000598 |
| FY 2024 | $-1.8M | 2024-01-01 – 2024-12-31 | evidence 0001640334-26-000598 |
| FY 2023 | $-1.2M | 2023-01-01 – 2023-12-31 | evidence 0001640334-24-000618 |
| FY 2022 | $-1.2M | 2022-01-01 – 2022-12-31 | evidence 0001640334-23-000632 |
| FY 2021 | $-1.5M | 2021-01-01 – 2021-12-31 | evidence 0001640334-22-000807 |
| FY 2020 | $247.3k | 2020-03-01 – 2020-12-31 | evidence 0001640334-21-001022 |
| FY 2019 | $-134.0k | 2019-03-01 – 2020-02-29 | evidence 0001193805-20-000741 |
| FY 2018 | $-148.0k | 2018-03-01 – 2019-02-28 | evidence 0001193805-19-000571 |
| FY 2017 | $-144.0k | 2017-03-01 – 2018-02-28 | evidence 0001193805-18-000835 |
| FY 2016 | $-224.0k | 2016-03-01 – 2017-02-28 | evidence 0001193805-17-001102 |
| FY 2015 | $-130.0k | 2015-03-01 – 2016-02-29 | evidence 0001193805-16-003444 |
| FY 2014 | $-116.0k | 2014-03-01 – 2015-02-28 | evidence 0001193805-15-000946 |
| FY 2013 | $-106.0k | 2013-03-01 – 2014-02-28 | evidence 0001193805-14-001196 |
| FY 2012 | $-103.0k | 2012-03-01 – 2013-02-28 | evidence 0001193805-13-001112 |
| FY 2011 | $-84.0k | 2011-03-01 – 2012-02-29 | evidence 0001193805-13-001112 |
| FY 2010 | $-110.0k | 2010-03-01 – 2011-02-28 | evidence 0001193805-12-001032 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
YUBO INTERNATIONAL BIOTECH LIMITED — all facts · Revenue · Operating Income